ClinicalTrials.gov record
Completed Early Phase 1 Interventional Results available

Extracorporeal Photopheresis (ECP) With Methoxsalen for Chronic Graft Versus Host Disease (cGVHD)

ClinicalTrials.gov ID: NCT01380535

Public ClinicalTrials.gov record NCT01380535. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 18, 2026, 2:51 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Controlled Study of Extracorporeal Photopheresis (ECP) Therapy With UVADEX for the Treatment of Patients With Moderate to Severe Chronic Graft-versus-Host Disease (cGvHD)

Study identification

NCT ID
NCT01380535
Recruitment status
Completed
Study type
Interventional
Phase
Early Phase 1
Lead sponsor
Mallinckrodt
Industry
Enrollment
60 participants

Conditions and interventions

Interventions

  • ECP Methoxsalen Drug
  • Standard of Care Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 99 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2011
Primary completion
Feb 28, 2015
Completion
Feb 28, 2015
Last update posted
Feb 18, 2020

2011 – 2015

United States locations

U.S. sites
11
U.S. states
8
U.S. cities
10
Facility City State ZIP Site status
University of Miami Hospital Miami Florida 33136
Indiana Blood and Marrow Transplantation Research Indianapolis Indiana 46237
Tulane University Health Sciences Center, 1430 Tulane Avenue, Rm 7551, New Orleans Louisiana 70112
Karmanos Cancer Institute Detroit Michigan 48201
Hackensack University Medical Center Hackensack New Jersey 07601
New York Presbyterian Hospital New York New York 10065
Stony brook university medical Center Stony Brook New York 11794
Vanderbilt Ingram Cancer Center Nashville Tennessee 37232
Medical City Dallas Hospital,Transplant center Dallas Texas 75230
Parkland Memorial Hospital Dallas Texas 75235
Methodist healthcare system of san Antonio San Antonio Texas 78229

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 21 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01380535, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 18, 2020 · Synced May 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01380535 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →